LOINC
Version 2.66

47237-3Treponema pallidum IgM Ab [Presence] in Serum by ImmunoassayActive

Component
Treponema pallidum Ab.IgM
Property
PrThr
Time
Pt
System
Ser
Scale
Ord
Method
IA

Additional Names

Short Name
T pallidum IgM Ser Ql IA
Display Name Beta
T. pallidum IgM IA Ql (S)
Consumer Name Alpha
Treponema pallidum IgM Antibody, Blood

Part Description

LP14042-3   Treponema pallidum
Treponema pallidum is a spirochaete bacterium. Pathogenic treponemes are classified based upon their clinical manifestations in humans: venereal syphilis, yaws, endemic syphilis and pinta. Nonpathogenic treponemes are often part of the normal flora of the genital tract, oral cavity or intestinal tract. Treponemal infections exhibit diverse clinical manifestations which are characterized by distinct clinical stages. Multiplication of the bacterium at the entry point causes the primary stage. Dissemination of treponemes to other tissues produces the second stage. After a latency period (up to 20 to 30 years), the tertiary stage develops. T. palladum subsp pallidum (venereal syphilis) is the most destructive subspecies and produces lesions in many bodily tissues including the central nervous system. Congenital syphilis may result in birth defects or fetal death. Venereal syphilis is sexually acquired except for congenital syphilis, which is transmitted to the fetus during the later stages of pregnancy. The other treponemes are acquired by close nonvenereal contact. Control of both venereal and nonvenereal disease is based upon surveillance and antibiotic treatment of contacts. [NCBI Books:NBK7716] Source: Regenstrief LOINC

Basic Attributes

Class
MICRO
Type
Laboratory
First Released
Version 2.19
Last Updated
Version 2.56
Change Reason
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016.
Order vs. Observation
Both

Member of these Panels

LOINC Long Common Name
54037-7 HEDIS 2009 panel
57820-3 HEDIS 2010 panel
60442-1 HEDIS 2011 panel
67767-4 HEDIS 2012 panel
72199-3 HEDIS 2013 panel
74234-6 HEDIS 2014 Value Sets

Member of these Groups

LG41621-0 Treponema pallidum

Language Variants Get Info

zh-CNChinese (China)
梅毒螺旋体 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法
nl-NLDutch (Netherlands)
Treponema pallidum As.IgM:aanwezigheid:moment:serum:ordinaal:immunoassay
et-EEEstonian (Estonia)
Treponema pallidum antikehad.IgM:PrThr:Pt:S:Ord:IA
fr-BEFrench (Belgium)
Treponema pallidum Anticorps. IgM:PrThr:Temps ponctuel:Sérum:Ordinal:IA
fr-CAFrench (Canada)
Treponema pallidum , IgM:Présence-Seuil:Temps ponctuel:Sérum:Ordinal:IA
fr-FRFrench (France)
Treponema pallidum Ab.IgM:PrThr:Pt:Ser:Ord:IA
de-ATGerman (Austria)
Trep.pall. AK IgM ql
de-DEGerman (Germany)
Treponema pallidum Ak.IgM:AKnz:Pkt:Ser:Ord:EIA
it-ITItalian (Italy)
Treponema pallidum , Ab.IgM:PrThr:Pt:Siero:Ord:IA
pt-BRPortuguese (Brazil)
Treponema pallidum Ac.IGM:ACnc:Pt:Soro:Ord:Imunoensaio
ru-RURussian (Russian Federation)
Treponema pallidum Ат.IgM:PrThr:ТчкВрм:Сыв:Пор:IA
es-ESSpanish (Spain)
Treponema pallidum IgM:PrThr:Punto temporal:Suero:Ord:IA
tr-TRTurkish (Turkey)
Treponema pallidum Ab.IgM:MevcEşik:Zmlı:Ser:Srl:İA

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=47237-3